Novolyze launches surrogates for process validations

Novolyze has launched a range of surrogate microorganisms that mimic the behaviour of food pathogens such as Salmonella and Listeria.

The food biotechnology company said SurroNov are non-pathogenic and can be used in-plant to validate efficacy of preventive controls on the microbial reduction of food products.

The first surrogate introduced is a strain for validation of low water activity foods (spices, nuts, powders, pet food etc).

It has been tested on thermal processes such as extruders, dryers, roasters and ovens.

The launch of the stabilized, dry and ready to use surrogate microorganisms is the result of several years of R&D as well as financial and human capital investments.

The BSL1 microorganisms are stable for several months, can be directly incorporated into a food matrix without an enrichment step and can reach inoculation levels up to 1010 CFU/g.

Jena Robers, VP business development at Novolyze, said first collaborations with several multinational food companies have been started.

“We are convinced that SurroNov surrogate microorganisms are a key tool for food companies to comply with FSMA Final Rule for Preventive Controls for Human Food.

“Our team is now focused on the evolution of the range and on the launch of other strains to complete our portfolio. Our ambition is to offer innovative solutions to our partners in order to better control microbiological hazards and improve food safety of processed foods.”